Sam – Page 520 – biolegacy

Roche Launches The Cobas EGFR Mutation Test V2 For Use With Either Plasma Or Tumor Tissue Samples

Post author:Sam
Post published:March 13, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

3 Dazzling Biotechs Poised to Soar Even More

Post author:Sam
Post published:March 13, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"3 Dazzling Biotechs Poised to Soar Even More" ALT"3 Dazzling Biotechs Poised to Soar Even More"March 14, 2017By Mark Terry, BioSpace.com Breaking News StaffAlthough 2016 wasnt a huge…

Peregrine Reports Financial Results For The Third Quarter Of Fiscal Year 2017 And Recent Developments

Post author:Sam
Post published:March 13, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

<b>Ackman</b> Is Finally Done With Valeant, Takes $2.8 Billion Loss and Will Step Down From Board

Post author:Sam
Post published:March 13, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-valeant.jpg" NAME"Ackman Is Finally Done With Valeant Takes $2.8 Billion Loss and Will Step Down From Board" ALT"Ackman Is Finally Done With Valeant Takes $2.8 Billion Loss and Will…

FDA Targets Infar over Testing, Records, Sanitation

Post author:Sam
Post published:March 13, 2017
Post category:Drug Industry Daily

Barcelona-based Infar received a Form 483 from the FDA for inadequate testing procedures, record-keeping, and sanitation. Source: Drug Industry Daily

Dr. Reddy’s Hit With Form 483 For Records, Testing Issues

Post author:Sam
Post published:March 13, 2017
Post category:Drug Industry Daily

The FDA slapped API manufacturer Dr. Reddy’s with a Form 483 over inadequate record-keeping and testing procedures. Source: Drug Industry Daily

FDA Mulls Establishing Patient Affairs Office to Support Drug Development

Post author:Sam
Post published:March 13, 2017
Post category:Drug Industry Daily

The FDA is considering establishing a new office for patient affairs to support the agency’s efforts to engage patients in the drug development process. Source: Drug Industry Daily

Gottlieb Nomination Draws Positive Reviews, And Some Questions

Post author:Sam
Post published:March 13, 2017
Post category:Drug Industry Daily

The administration’s plan to nominate Scott Gottlieb as FDA commissioner drew generally positive reactions on Capitol Hill and from drugmakers — but also some concerns from other stakeholders over his…

Shakeup at Intrexon as a Subsidiary is Created and an Ex-Pfizer Exec Exits in Reorg

Post author:Sam
Post published:March 12, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks-down3.jpg" NAME"Shakeup at Intrexon as a Subsidiary is Created and an Ex-Pfizer Exec Exits in Reorg" ALT"Shakeup at Intrexon as a Subsidiary is Created and an Ex-Pfizer Exec Exits…

DexCom Appoints To Board Of Directors

Post author:Sam
Post published:March 12, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace